We are live on ! Find out more
BS

Bow Street Portfolio holdings

AUM $52.4M
1-Year Est. Return 2.22%
This Fund
S&P 500
This Quarter Est. Return
-14.94%
1 Year Est. Return
-2.22%
3 Year Est. Return
+43.3%
5 Year Est. Return
10 Year Est. Return
AUM
$34.6M
AUM Growth
+$9.97M
Cap. Flow
+$17.2M
Cap. Flow %
49.8%
Top 10 Hldgs %
100%
Holding
2
New
1
Increased
1
Reduced
Closed

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NRE
1
DELISTED
NorthStar Realty Europe Corp.
NRE
$27.2M 78.69%
2,942,678
+820,380
+39% +$9.2M
ADMS
2
DELISTED
Adamas Pharmaceuticals
ADMS
$7.37M 21.31%
+486,747
New +$8.02M

Similar funds

Bow Street's Q2 2016 Portfolio in Review

As of Q2 2016, Bow Street held 2 positions worth $34.6M, up 40% from $24.6M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Bow Street deployed $17.2M of net new capital in Q2 2016, opening 1 new position and adding to 1 existing holding. Its largest new stake was Adamas Pharmaceuticals: 486,747 shares worth $7.37M.

  • Bow Street's largest Q2 2016 buy was Adamas Pharmaceuticals: 486,747 shares worth $7.37M.
  • Bow Street added most to NorthStar Realty Europe Corp. in Q2 2016, an estimated $9.2M increase.
  • Bow Street's ten largest holdings make up 100% of its $34.6M portfolio in Q2 2016.
  • Bow Street opened 1 new position and closed 0 in Q2 2016.
  • Bow Street's portfolio value rose 40% quarter-over-quarter to $34.6M.

Based on Bow Street's 13F filing for Q2 2016, filed 15 Aug 2016.